Clinical trials: Leukoencephalopathies
Cree Leukoencephalopathy, Vanishing White Matter
Research Study for Single-Patient Treatment of Cree Leukoencephalopathy/Vanishing White Matter Disease
Cree Leukoencephalopathy (CLE) is a rare and fatal neurodegenerative disorder predominantly affecting the Cree population in Northern Quebec.
- Trial name
- NCT07272525
- Testing
- Fosigotifator (FGT/ABBV-CLS-7262)
- Where
- Canada
- Volunteers
- 1 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre